Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Update on Biologic Therapies for Systemic Lupus Erythematosus
Helena Hiemisch Lobo Borba, Andreas Funke, Astrid Wiens, et al.
Current Rheumatology Reports (2016) Vol. 18, Iss. 7
Closed Access | Times Cited: 11

Showing 11 citing articles:

Pathogenesis of Human Systemic Lupus Erythematosus: A Cellular Perspective
Vaishali R. Moulton, Abel Suárez‐Fueyo, Esra Meidan, et al.
Trends in Molecular Medicine (2017) Vol. 23, Iss. 7, pp. 615-635
Open Access | Times Cited: 403
B cells expressing the transcription factor T-bet drive lupus-like autoimmunity
Kira Rubtsova, Anatoly V. Rubtsov, Joshua M. Thurman, et al.
Journal of Clinical Investigation (2017) Vol. 127, Iss. 4, pp. 1392-1404
Open Access | Times Cited: 241
Intracellular Nucleic Acid Detection in Autoimmunity
John T. Crowl, Elizabeth Gray, Kathleen Pestal, et al.
Annual Review of Immunology (2017) Vol. 35, Iss. 1, pp. 313-336
Open Access | Times Cited: 199
TNFAIP3 downregulation mediated by histone modification contributes to T-cell dysfunction in systemic lupus erythematosus
Hongjun Zhao, Lijing Wang, Hui Luo, et al.
Lara D. Veeken (2017) Vol. 56, Iss. 5, pp. 835-843
Open Access | Times Cited: 36
Biologic Therapies for Autoimmune and Connective Tissue Diseases
Rachel Wolfe, Dennis C. Ang
Immunology and Allergy Clinics of North America (2017) Vol. 37, Iss. 2, pp. 283-299
Closed Access | Times Cited: 32
Ocular Involvement in Systemic Lupus Erythematosus: The Experience of Two Tertiary Referral Centers
Rosanna Dammacco, P Procaccio, Vito Racanelli, et al.
Ocular Immunology and Inflammation (2018) Vol. 26, Iss. 8, pp. 1154-1165
Closed Access | Times Cited: 31
Biotherapy in Inflammatory Diseases of the CNS: Current Knowledge and Applications
Nicolas Collongues, Laure Michel, de Sèze
Current Treatment Options in Neurology (2017) Vol. 19, Iss. 5
Closed Access | Times Cited: 6
Cellular Microvesicles in the Blood of Patients with Systemic Lupus Erythematosus
Т. А. Невзорова, Natalia G. Evtugina, Rustem I. Litvinov
BioNanoScience (2017) Vol. 8, Iss. 1, pp. 441-445
Closed Access | Times Cited: 3
Treatment of SLE and Secondary Sjogren’s Syndrome with Belimumab
Riaz Ahmad, Charles J. Malemud, Ali Askari
Journal of Immunobiology (2016) Vol. 01, Iss. 04
Closed Access | Times Cited: 1
Immunotherapies in Late-Stage Development for Patients With Severe SLE and/or Lupus Nephritis.
Chris Fellner
PubMed (2017) Vol. 42, Iss. 6, pp. 394-397
Closed Access | Times Cited: 1
Challenges in the Development of drugs for Systemic Lupus Erythematosus: A Regulatory Perspective
Alfred M. Del Vecchio, Marc Chévrier, Drew R. Elias, et al.
Journal of Regulatory Science (2019), pp. 1-13
Open Access
Page 1

Scroll to top